2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Intraocular deposits and cataracts after long-term rifabutin intake : A case report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale:

          Rifabutin is a broad-spectrum antibiotic known to cause deposits on the corneal endothelium and lens. We report a patient in whom cataracts developed and progressive pigment deposits were seen on the corneal endothelium, lens, and iridocorneal angle.

          Patient concerns:

          The patient was a 45-year-old woman who had been received long-term treatment with a combination of various anti-mycobacterial drugs for multidrug-resistant tuberculosis starting in 2004. Rifabutin was started in 2009, and she was referred to our department in 2017 for detailed ophthalmological examination.

          Diagnoses:

          Both eyes showed pigmented deposits over the entire corneal endothelium, the entire periphery of the iridocorneal angle, and the anterior surface of the lens. Mild cataracts were also diagnosed bilaterally. Pigment deposits on the anterior surface of the lens and the cataracts in both eyes gradually progressed. These lesions were assumed to be associated with long term rifabutin intake.

          Interventions:

          Rifabutin intake was discontinued after progression of intraocular deposits, cataracts, and ERG deterioration.

          Outcomes:

          Visual acuity improved, although cataracts, deposits, and ERG deterioration remained.

          Lessons:

          Rifabutin may induce not only corneal endothelial deposits, but also cataracts and iridocorneal angle deposits.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Drug-induced corneal complications.

          To review the common corneal manifestations of systemic medications in order to describe the characteristic clinical features associated with particular systemic drugs, the indications for drug cessation, and the risks for irreversible ocular toxicity. Systemic medications may reach the cornea via the tear film, aqueous humor, and limbal vasculature. The corneal changes are often the result of the underlying chemical properties of medications. Amphiphilic medications (amiodarone, chloroquine, suramin, clofazimine, etc.) may produce a drug-induced lipidosis and development of a vortex keratopathy. Antimetabolites (cytarabine) may lead to a degeneration of basal epithelial cells with formation of epithelial microcysts. Additionally, systemically administered medications and drug metabolites may lead to a stromal or endothelial deposition. Corneal changes may result in reduced visual acuity, photophobia, and ocular irritation, though these symptoms typically resolve following drug cessation. Corneal manifestations of systemic medications are often dose related, and may reflect the potential risk for lenticular or retinal changes. Corneal changes secondary to systemic medications may affect all layers of the cornea. While corneal deposition is typically not an indication for drug cessation, patients receiving particular medications should be monitored for symptoms related to corneal deposition as well as for signs of irreversible ocular toxicity.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Overview of toxicological data on Riffabutin

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for mycobacterium avium complex bacteremia

                Bookmark

                Author and article information

                Journal
                Medicine (Baltimore)
                Medicine (Baltimore)
                MEDI
                Medicine
                Wolters Kluwer Health
                0025-7974
                1536-5964
                May 2020
                22 May 2020
                : 99
                : 21
                : e20049
                Affiliations
                Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Japan.
                Author notes
                []Correspondence: Masafumi Uematsu, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, Nagasaki 852-8501, Japan (e-mail: uematsu1124@ 123456outlook.jp ).
                Article
                MD-D-19-04725 20049
                10.1097/MD.0000000000020049
                7249992
                32481272
                e1214f7a-ce5e-46da-a4ba-db34a0f0b2c9
                Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0

                History
                : 22 June 2019
                : 08 February 2020
                : 26 March 2020
                Categories
                5800
                Research Article
                Clinical Case Report
                Custom metadata
                TRUE

                cataracts,corneal endothelial deposits,intraocular deposits,iridocorneal angle deposits,rifabutin

                Comments

                Comment on this article